Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,694 | 9,652 | 3,987 | 7,901 | 1,825 |
| Marketable Securities | 3,877 | 7,549 | 14,455 | 23 | 23 |
| Receivables | 554 | 313 | 292 | 236 | 266 |
| Inventories | N/A | N/A | N/A | 30 | 30 |
| Other current assets | 0 | 0 | 0 | 0 | 43 |
| TOTAL | $16,484 | $17,763 | $18,874 | $8,353 | $2,266 |
| Non-Current Assets | |||||
| PPE Net | 44 | 45 | 44 | 48 | 51 |
| TOTAL | $44 | $45 | $44 | $48 | $51 |
| Total Assets | $16,528 | $17,808 | $18,918 | $8,401 | $2,318 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 64 | 41 | 39 | 41 | 60 |
| Accounts payable and accrued liabilities | 2,400 | 1,252 | 1,643 | 995 | 998 |
| TOTAL | $2,464 | $1,293 | $1,683 | $1,036 | $1,057 |
| Non-Current Liabilities | |||||
| Long Term Debt | 733 | 720 | 685 | 715 | 707 |
| TOTAL | $733 | $720 | $685 | $715 | $707 |
| Total Liabilities | $3,197 | $2,013 | $2,368 | $1,751 | $1,764 |
| Shareholders' Equity | |||||
| Common Shares | 26,637 | 25,455 | 24,390 | 15,782 | 10,730 |
| Retained earnings | -19,929 | -16,290 | -13,870 | -12,499 | -11,622 |
| Other shareholders' equity | 4,813 | 4,816 | 4,642 | 2,004 | 233 |
| TOTAL | $13,331 | $15,795 | $16,550 | $6,650 | $554 |
| Total Liabilities And Equity | $16,528 | $17,808 | $18,918 | $8,401 | $2,318 |